查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467816

2024-2032 年骨關節炎治療市場報告（依解剖類型、藥物類型、給藥途徑、配銷通路和地區）

Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球骨關節炎治療市場規模達79億美元。

骨關節炎 (OA) 是一種異質性疾病，其特徵是膝蓋、臀部、手、腳、脊椎、肩膀和頸部關節的軟骨進行性退化。骨關節炎通常會導致僵硬、腫脹、壓痛、持續疼痛、失去靈活性、刺痛感、骨刺和睡眠障礙。可以透過身體檢查、X 光、關節鏡檢查、關節液分析、血液檢查和磁振造影 (MRI) 掃描來診斷。根據不同的結果開立各種藥物和手術程序來減輕疾病的徵兆和症狀。目前，市面上有替代藥物、物理治療和支持裝置來緩解疼痛和改善關節功能。

全球骨關節炎治療市場趨勢與促進因素：

久坐的生活方式、不健康的飲食模式以及肥胖和血糖盛行率的上升正在增加個體患骨關節炎的風險。這與日益成長的老年人口（更容易患此類疾病）相結合，是推動骨關節炎治療市場成長的關鍵因素之一。除此之外，易於取得核磁共振掃描是另一個主要的生長誘導因素。此外，基於放射學特徵的成像生物標記的開發，加上鎮痛藥物的引入，正在促進市場的成長。此外，為推出新的診斷方法和生物標記而對研發（R＆D）活動的​​投資不斷增加，以及改善醫療基礎設施的支出不斷增加，也正在推動市場發展。例如，疾病緩解藥物正在開發中，其重點是促發炎細胞因子來治療軟骨損傷。

本報告回答的關鍵問題

  • 2023年全球骨關節炎治療市場規模有多大？
  • 2024-2032年全球骨關節炎治療市場的預期成長率是多少？
  • 推動全球骨關節炎治療市場的關鍵因素是什麼？
  • COVID-19 對全球骨關節炎治療市場有何影響？
  • 根據解剖類型，全球骨關節炎治療市場的細分如何？
  • 根據藥物類型，全球骨關節炎治療市場的細分如何？
  • 根據給藥途徑，全球骨關節炎治療市場的細分如何？
  • 基於配銷通路的全球骨關節炎治療市場的詳細情形如何？
  • 全球骨關節炎治療市場的關鍵地區有哪些？
  • 誰是全球骨關節炎治療市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球骨關節炎治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依解剖類型

  • 膝蓋
    • 市場走向
    • 市場預測
  • 時髦的
    • 市場走向
    • 市場預測
  • 手
    • 市場走向
    • 市場預測
  • 脊椎
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按藥物類型

  • 非類固醇抗發炎藥
    • 市場走向
    • 市場預測
  • 止痛藥
    • 市場走向
    • 市場預測
  • 皮質類固醇
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依管理途徑

  • 注射用
    • 市場走向
    • 市場預測
  • 專題
    • 市場走向
    • 市場預測
  • 口服
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按配銷通路

  • 醫院
    • 市場走向
    • 市場預測
  • 專科診所
    • 市場走向
    • 市場預測
  • 醫療機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Anika Therapeutics Inc.
    • Bayer Aktiengesellschaft
    • Eli Lilly and Company
    • Flexion Therapeutics Inc.
    • GlaxoSmithKline Plc
    • Horizon Therapeutics Plc
    • Johnson & Johnson Inc.
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112024A2791

The global osteoarthritis therapeutics market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032.

Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.

Global Osteoarthritis Therapeutics Market Trends and Drivers:

Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the osteoarthritis therapeutics market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global osteoarthritis therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on anatomy type, drug type, route of administration and distribution channel.

Breakup by Anatomy Type:

Knee

Hip

Hand

Spine

Others

Breakup by Drug Type:

Nonsteroidal Anti-Inflammatory Drugs

Analgesics

Corticosteroids

Others

Breakup by Route of Administration:

Parenteral

Topical

Oral

Breakup by Distribution Channel:

Hospitals

Specialty Clinics

Medical Institutions

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report

  • 1. What was the size of the global osteoarthritis therapeutics market in 2023?
  • 2. What is the expected growth rate of the global osteoarthritis therapeutics market during 2024-2032?
  • 3. What are the key factors driving the global osteoarthritis therapeutics market?
  • 4. What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
  • 5. What is the breakup of the global osteoarthritis therapeutics market based on the anatomy type?
  • 6. What is the breakup of the global osteoarthritis therapeutics market based on the drug type?
  • 7. What is the breakup of the global osteoarthritis therapeutics market based on the route of administration?
  • 8. What is the breakup of the global osteoarthritis therapeutics market based on the distribution channel?
  • 9. What are the key regions in the global osteoarthritis therapeutics market?
  • 10. Who are the key players/companies in the global osteoarthritis therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Osteoarthritis Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Anatomy Type

  • 6.1 Knee
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hand
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Spine
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Nonsteroidal Anti-Inflammatory Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Analgesics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Corticosteroids
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Parenteral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Topical
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Oral
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Institutions
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Anika Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Eli Lilly and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Flexion Therapeutics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 GlaxoSmithKline Plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Horizon Therapeutics Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Osteoarthritis Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2023
  • Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2023
  • Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million US$), 2018 & 2023

Figure 12 Global: Osteoarthritis Therapeutics (Hip) Market Forecast: Sales Value (in Million US$), 2024-2032

  • Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
  • Figure 90: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
  • Figure 91: Global: Osteoarthritis Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Osteoarthritis Therapeutics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Anatomy Type (in Million US$), 2024-2032
  • Table 3: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Osteoarthritis Therapeutics Market: Competitive Structure
  • Table 8: Global: Osteoarthritis Therapeutics Market: Key Players